Latest News

Picture Irimajiri Announcement

Iktos announces Research Collaboration in Oncology with Irimajiri, leader in peptide mimetic chemistry

Read the article10.01.2025

Press release

Picture Irimajiri Announcement
10.01.2025

Iktos announces Research Collaboration in Oncology with Irimajiri, leader in peptide mimetic chemistry

Dr. Ashiq H. Khan PR announcement
09.03.2025

Iktos announces the appointment of Dr. Ashiq H. Khan as Chief Business Officer

Iktos brings Makya, its AI-Driven Drug Design Tool, to the AWS Marketplace
05.06.2025

Iktos brings Makya, its AI-Driven Drug Design Tool, to the AWS Marketplace

Press articles and news

Nine promising small molecule drug discovery companies to look out for in 2025

Nine promising small molecule drug discovery companies to look out for in 2025

We are proud to be featured in Labiotech.eu’s roundup of “9 Small Molecule Drug Discovery Companies to Look Out for in 2025”!

Read the article
LaBiotech.eu |05.16.2025
Nine promising small molecule drug discovery companies to look out for in 2025
LaBiotech.eu | 05.16.2025

Nine promising small molecule drug discovery companies to look out for in 2025

Medicinal chemistry: the next step for AI-designed drugs
Manufacturing Chemist | 05.12.2025

Medicinal chemistry: the next step for AI-designed drugs

Nicolas Do Huu: «Avec l’IA, Iktos veut réduire de moitié le temps de découverte des médicaments»
Le Figaro | 02.11.2025

Nicolas Do Huu: «Avec l’IA, Iktos veut réduire de moitié le temps de découverte des médicaments»

Press Kit

Logos
LogosDownload
Photographies
PhotographiesDownload
Contact

Contact

For any communication need please contact our agency.

Ulysse Communication
Mail :  iktosteam@ulysse-communication.com
Tel. : +33663665922